Investors & Media

Tracey is an experienced legal professional with over 25 years of legal, management and transactional experience in the biopharmaceutical industry. Most recently, Tracey served as senior vice president and head of legal for Sanofi Genzyme, a global business unit of Sanofi, as well as a member of Sanofi Genzyme’s executive leadership team and as a member of the leadership team for Sanofi’s global legal department. Prior to that, Tracey served as Genzyme’s general counsel after it was acquired by Sanofi in 2011. In her capacity as Genzyme’s general counsel, Tracey was responsible for all aspects of its legal department in the United States and throughout Europe, including general corporate, commercial and intellectual property matters, and support of business development initiatives. Prior to Genzyme’s acquisition, Tracey was also responsible for managing the securities and employment law teams and support of non-patent litigation. Before Genzyme, Tracey was an associate at the law firm Palmer & Dodge LLP. She currently sits on the boards of directors at Kiniksa Pharmaceuticals and ImmunoGen, as well as the board of trustees at Dana Farber Cancer Institute. Tracey received her B.A. in political science from the University of Pennsylvania and her J.D. from Columbia University School of Law.